Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Management of Low Risk Ductal Carcinoma in Situ (Low-risk DCIS): a Non-randomized, Multicenter, Non-inferiority Trial; Standard Therapy Approach Versus Active Surveillance

NCT02492607 is registered in ClinicalTrials.gov with The Netherlands Cancer Institute as lead sponsor.

NCT NCT02492607
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02492607 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Management of Low Risk Ductal Carcinoma in Situ (Low-risk DCIS): a Non-randomized, Multicenter, Non-inferiority Trial; Standard Therapy Approach Versus Active Surveillance
Lead sponsor
The Netherlands Cancer Institute
Phase
Not applicable
Overall status
Active, not recruiting
Start date
February 13, 2017
Completion date
February 1, 2034
Enrollment
2,500 (estimated)
Sites
60

Conditions

As the registry lists them; a condition with its own page is linked.

dcis